UCSF researchers triggered cellular transformation — and caused tumors to form in mice — by activating just two genes, a discovery that suggests drugs that are able to target those genes may provide a way to treat the deadly cancer, known as cholangiocarcinoma.
July 10, 2012
Cancer patients across the country have a new way to navigate through difficult treatment decisions and communicate better with their doctors. “Open to Options,’’ which recently launched nationally, was developed in conjunction with UCSF to guide patients in making critical health decisions.
July 01, 2012
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when. And for far too many, it happens far too soon.
June 15, 2012
Vitamin D and calcium to prevent bone fractures in healthy, postmenopausal women does not work, at least at low supplemental doses, according to the United States Preventive Services Task Force.
June 14, 2012
A new approach to drug design, pioneered by a group of researchers at UCSF and Mt. Sinai, New York, promises to help identify future drugs to fight cancer and other diseases that will be more effective and have fewer side effects.
June 11, 2012
The single thing that a woman can do to lower her risk of breast cancer is to avoid unnecessary medical imaging, says Rebecca Smith-Bindman, MD, a professor of radiology and biomedical imaging, epidemiology and biostatistics at UCSF, who contributed to a new Institute of Medicine report.
May 23, 2012
Construction of UCSF Medical Center at Mission Bay is well underway, with the building’s exterior panels, glass, and interior studs being installed.
May 18, 2012
To celebrate nearly a quarter-century of advances in hematology and transplantation, UCSF is holding a reunion of patients from the UCSF Medical Center who have undergone bone marrow transplants.
May 02, 2012
A pioneering approach to imaging breast cancer in mice has revealed new clues about why the human immune system often fails to attack tumors and keep cancer in check. This observation, by scientists at the University of California, San Francisco (UCSF), may help to reveal new approaches to cancer immunotherapy.
May 01, 2012
In a study of patients 65 and older with non-small-cell lung cancer (NSCLC), younger patients were more likely to receive treatment than older patients, regardless of overall health and prognosis.